The Evidence Base
Post
PDUFA VII and the FDA Advancing Real-World Evidence Program: an interview with Lucy Vereshchagina, PhRMA
Following reauthorization of the seventh iteration of the Prescription Drug User Fee Amendments (...
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.